Attilio Losito

Attilio Losito

Auto-generated profile, based on publicly available information

Attilio Losito

Ospedale Santa Maria della Misericordia

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 May 2005 in Nephrology Dialysis Transplantation
Verified
Journal Article
Closed access
PDF file
ALAttilio Losito
Attilio Losito
RERosa Errico
Rosa Errico
PSPaola Santirosi
Paola Santirosi
TLTommaso Lupattelli
Tommaso Lupattelli
GSGiovanni Battista Scalera
Giovanni Battista Scalera
LLLuciano Lupattelli
Luciano Lupattelli
Background. Patients with atherosclerotic renovascular disease (ARVD) are almost invariably treated by revascularization. However, the long-term outcomes of this approach on survival and progression to renal failure have not been investigated and have not been compared with that of a purely medical treatment. The aim of this observational study was to investigate factors affecting long-term (over 5 years) outcome, survival and renal function of patients with ARVD treated invasively or medically.

1 August 2003 in Kidney International
Verified
Journal Article
Closed access
ALAttilio Losito
Attilio Losito
KKKamini Kalidas
Kamini Kalidas
SSStefania Santoni
Stefania Santoni
SJSteve Jeffery
Steve Jeffery

31 May 2017 in Journal Of Nephrology
Verified
Journal Article
Closed access
PDF file
ALAttilio Losito
Attilio Losito
ENEmidio Nunzi
Emidio Nunzi
LPLoretta Pittavini
Loretta Pittavini
IZIvano Zampi
Ivano Zampi
EZElena Zampi
Elena Zampi
The cardiovascular risk associated with an increase in serum creatinine below the acute kidney injury (AKI) threshold, during hospitalization, has not been studied in depth. We assessed patients’ features and outcomes associated with these changes.

10 July 2011 in Nephrology Dialysis Transplantation
Verified
Journal Article
Open access
PDF file
ALAttilio Losito
Attilio Losito
LPLoretta Pittavini
Loretta Pittavini
CFCarla María Ferri
Carla María Ferri
LALuigi De Angelis
Luigi De Angelis
Stroke is a dangerous long-term complication of kidney failure, yet its occurrence early in disease is poorly characterized. Our aim was to investigate the association of reduced kidney function, hypertension and diabetes with acute ischaemic stroke and the outcome thereof. In this prospective cohort study, the association of reduced kidney function, hypertension and diabetes with stroke and 2-year all-cause mortality was investigated. Glomerular filtration rate (eGFR) was estimated by the simplified Modification of Diet in Renal Disease formula in 13 365 consecutive patients (671 with acute ischaemic stroke) admitted to our clinical facility over a 12-month period. Ischaemic stroke, after adjustment for age and gender, was significantly associated with eGFR <60 mL/min/1.73m 2 [odds ratio (OR) 1.53, 95% confidence interval (CI) 1.30–1.81], hypertension (2.77, 95% CI 2.33–3.28) and diabetes (1.30, 95% CI 1.04–1.63). Multivariate analysis of interaction indicated the absence of an additive effect between eGFR, hypertension and diabetes, on the risk of stroke. Age and gender-adjusted survival analysis by Cox regression showed an association of mortality with reduced eGFR alone (HR = 4.29, 95% CI 1.02–19.60). In patients acutely admitted to hospital, reduced kidney function, hypertension and diabetes are independently associated with ischaemic stroke, but do not exert a synergic effect. After hospital discharge, mortality is strongly associated with reduced eGFR but with neither hypertension nor diabetes.

1 February 2000 in American Journal of Kidney Diseases
Verified
Journal Article
Closed access
ALAttilio Losito
Attilio Losito
BPBasso Parente
Basso Parente
PCPier Giorgio Cao
Pier Giorgio Cao
SJSteve Jeffery
Steve Jeffery
AAAli R. Afzal
Ali R. Afzal

1 December 2002 in Nephrology Dialysis Transplantation
Verified
Journal Article
Open access
PDF file
ALAttilio Losito
Attilio Losito
KKKamini Kalidas
Kamini Kalidas
SSStefania Santoni
Stefania Santoni
LCLuigi Ceccarelli
Luigi Ceccarelli
SJSteve Jeffery
Steve Jeffery
Background. Polymorphisms of genes of the renin–angiotensin system (RAS) have been found in association with cerebrovascular and cardiovascular diseases in the general population. In dialysis patients, RAS gene polymorphisms have been studied in combination and separately and have yielded conflicting results. Methods. In this study we have analysed, in 160 dialysis patients, the distribution of the following genetic polymorphisms: M235T and T174M of the angiotensinogen gene, A1166C of the angiotensin II type 1 receptor gene and the insertion/deletion (I/D) of the ACE gene. The association of these polymorphisms with cerebrovascular and cardiovascular diseases was also tested. Healthy blood donors and hospital staff (169) were the control group for the distribution of the polymorphisms. Results. The distribution of the polymorphisms in dialysis patients as a whole did not differ significantly from that of healthy controls. However, for patients with severe cerebrovascular disease, 70% carried the D allele compared with 52% of patients without cerebrovascular disease (P=0.035). We also found that the degree of carotid artery stenosis was significantly correlated with the presence of the ACE ‘D’ allele in subjects on dialysis (P=0.0348). Conclusions. The distribution of RAS genes in dialysis patients is similar to that of the normal population. The presence of the D allele of ACE gene is associated with cerebrovascular disease and the degree of carotid artery stenosis. We postulate that the ACE gene polymorphism is a risk factor for cerebrovascular disease in dialytic patients.